Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 3 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
yongjian yu
(30 results)?
CircRNAs in cancer metabolism: a review.
J Hematol Oncol. 2019 Sep 4;12(1):90. doi: 10.1186/s13045-019-0776-8.
J Hematol Oncol. 2019.
PMID: 31484561
Free PMC article.
Review.
LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.
Xu TP, Yu T, Xie MY, Fang Y, Xu TT, Pan YT, Ma P, Shu YQ.
Xu TP, et al.
Gastric Cancer. 2023 Mar;26(2):169-186. doi: 10.1007/s10120-022-01348-z. Epub 2022 Oct 25.
Gastric Cancer. 2023.
PMID: 36284068
Item in Clipboard
A novel strategy to construct Janus metallamacrocycles with both a Ru-arene face and an imidazolium face.
Li J, Zhang P, Xu Y, Su Z, Qian Y, Li S, Yu T, Sadler PJ, Liu HK.
Li J, et al.
Dalton Trans. 2017 Nov 28;46(46):16205-16215. doi: 10.1039/c7dt03374e.
Dalton Trans. 2017.
PMID: 29182689
Item in Clipboard
Creep Mechanisms of an Al-Cu-Mg Alloy at the Macro- and Micro-Scale: Effect of the S'/S Precipitate.
Xu Y, Yang L, Zhan L, Yu H, Huang M.
Xu Y, et al.
Materials (Basel). 2019 Sep 9;12(18):2907. doi: 10.3390/ma12182907.
Materials (Basel). 2019.
PMID: 31505758
Free PMC article.
Item in Clipboard
KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome.
Xu TP, Ma P, Wang WY, Shuai Y, Wang YF, Yu T, Xia R, Shu YQ.
Xu TP, et al.
Cell Death Differ. 2019 Nov;26(11):2179-2193. doi: 10.1038/s41418-018-0236-y. Epub 2019 Feb 15.
Cell Death Differ. 2019.
PMID: 30770877
Free PMC article.
Item in Clipboard
Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study.
Qin S, Li J, Bai Y, Shu Y, Li W, Yin X, Cheng Y, Sun G, Deng Y, Zhong H, Li Y, Qian X, Zhang L, Zhang J, Chen K, Kang W; HLX04-mCRC03 Investigators.
Qin S, et al.
BioDrugs. 2021 Jul;35(4):445-458. doi: 10.1007/s40259-021-00484-9. Epub 2021 May 20.
BioDrugs. 2021.
PMID: 34014555
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite